| 1 |
10850338 | Phase I study of R24 in patients with metastatic melanoma including evaluation of immunologic parameters. | 1998 Feb |
1 |
| 2 |
3665201 | Immune and nonimmune effector functions of IgG3 mouse monoclonal antibody R24 detecting the disialoganglioside GD3 on the surface of melanoma cells. | 1987 Nov |
1 |
| 3 |
3091900 | Complete tumor ablation with iodine 131-radiolabeled disialoganglioside GD2-specific monoclonal antibody against human neuroblastoma xenografted in nude mice. | 1986 Sep |
1 |
| 4 |
3094017 | Lymphokine-activated killer cells targeted by monoclonal antibodies to the disialogangliosides GD2 and GD3 specifically lyse human tumor cells of neuroectodermal origin. | 1986 Oct |
1 |
| 5 |
3860849 | Disialoganglioside GD3 on human melanoma serves as a relevant target antigen for monoclonal antibody-mediated tumor cytolysis. | 1985 Aug |
1 |